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Editorial
The development of a new strategy in the management of bone and 
soft tissue tumors
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Recent improvements in outcomes including survival 
prognosis and functional recovery for bone and soft 
tissue tumors have been remarkable. These improve-
ments are due to advantageous adjuvant therapy that is 
the combined result of the development and adminis-
tration protocols or plans for new anti-tumor medicines 
or new radiation therapy, and skillful surgical procedure 
consisting of complete excision based on a surgical stag-
ing system and reconstruction. Among these treatments, 
complete excision of the primary lesion is the most im-
portant for obtaining a good survival prognosis, because 
surgical treatment leads to greater effi cacy of adjuvant 
therapy. Therefore, it would not be an exaggeration to 
say that surgical treatment plays a central role in the 
present treatment of bone and soft tissue tumors.
To surgically excise a primary lesion reliably, it is 
important to apply an adequate surgical margin based 
on accurate grading of the tumor’s malignancy. Thus, it 
is necessary to utilize a surgical staging system. Re-
cently, several surgical staging systems have been pro-
posed; however, there is no consensus on which systems 
are clinically available.
During my 2 years (1980–82) abroad at the Depart-
ment of Orthopedic Surgery at the University of 
Florida, I personally observed for the fi rst time a sys-
tematic surgical treatment using a surgical staging sys-
tem developed by William F. Enneking. I still remember 
that I was surprised at the difference in thinking be-
tween Japan and the United States regarding treatment. 
Upon returning to Japan, I introduced Enneking’s sur-
gical staging system to Japanese orthopedic surgeons. 
Many of my surgical cases have focused on this surgical 
staging system with a slightly reduced radical margin. 
From these experiences, I consider Enneking’s surgical 
staging system to be the most clinically valid. Ennek-
ing’s system classifi es tumors into 5 stages based on the 
grade of malignancy, invasive extension, and presence 
or absence of metastasis. Therefore, the fi rst steps to-
ward accurate application of the system are the correct 
diagnosis based on histopathological classifi cation and 
the evaluation of the invasiveness.
To make a correct diagnosis, accurate understanding 
of imaging and histopathological fi ndings is critical. Re-
cently, many young orthopedic physicians tend to rely 
most on magnetic resonance imaging (MRI) fi ndings 
when making a diagnosis of any disease or trauma case. 
However, for bone tumors, plain radiography is the 
most important diagnostic imaging. Although MRI and 
computed tomography (CT) are very useful in evaluat-
ing invasive extension, they contribute little to diagno-
sis. On the other hand, CT and MRI are important in 
the clinical diagnosis of soft tissue tumors. It is impor-
tant for young orthopedic physicians to use the most 
suitable imaging for a disease or trauma. Particularly 
in cases with tumors, it is very important to select an 
appropriate examination method to obtain a correct 
diagnosis.
The fi rst step toward making a correct diagnosis with 
histopathological fi ndings is an adequate biopsy. There 
are two types of biopsy, needle and open. I performed 
the latter as a general rule. The accuracy of diagnosis is 
reported to be about 90% or more for needle biopsy. 
However, most of that 90% may be diagnosed by clini-
cal and radiological fi ndings, because mesenchymal 
malignant tumors have various histological features. I 
believe that needle biopsy may be useful for confi rming 
the fi nal diagnosis obtained by clinical and radiological 
fi ndings in these cases. Thus, open biopsy is the general 
rule. When performing such a biopsy, one must send a 
small specimen of tumor tissue to the pathology depart-
ment to obtain a pathological diagnosis with the frozen 
section. Even if it is diffi cult to obtain a diagnosis, one 
can confi rm the inclusion of tumor tissue in the har-
vested specimens. At present, there is controversy re-
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garding the usefulness of frozen sections. The question 
will be discussed in this scientifi c meeting, but I consider 
open biopsy and immediate pathological diagnosis with 
a frozen section extremely important in accurate histo-
pathological diagnosis and in planning how to excise the 
lesions.
It is becoming more common to depend on radiolo-
gists and pathologists to perform a diagnosis based on 
imaging and histopathological data. It is commonly 
agreed that it is extremely important for each medical 
specialist to accurately interpret the data to make a cor-
rect diagnosis. The importance of cooperation among 
orthopedic surgeons, radiologists, and pathologists 
has always been emphasized. I believe that the central 
fi gure in this cooperation should be the orthopedic 
surgeon, who always bears responsibility for patient 
outcomes. Therefore, an orthopedic surgeon who may 
treat tumors must become knowledgeable in imaging 
and histopathology in order to better communicate with 
radiologists and pathologists, particularly to discuss a 
questionable diagnosis.
After diagnosis, whether to perform preoperative 
chemotherapy depends on the histological diagnosis 
and tumor site, but chemotherapy is necessary for most 
tumors from the aspect of reducing the primary tumor 
size and control of micrometastasis. However, the ef-
fectiveness of chemotherapy on each of the different 
histological types has not been fully demonstrated clini-
cally. One reason for this situation is the rare occur-
rence of bone and soft tissue sarcoma compared with 
the occurrence of carcinoma, and another is the scarcity 
of data on the effectiveness of chemotherapy. To re-
solve this problem, a multicenter study is necessary, and 
its development is just beginning. The immediate estab-
lishment of this system is important to obtain better 
outcomes for bone and soft tissue sarcoma.
For planning the surgery, fi rst an appropriate surgical 
margin must be determined; but at this stage, one must 
not think about the reconstruction after excision of the 
primary lesion for preserving the affected limb. As a 
result of reliable excision of the primary lesion with an 
adequate surgical margin, a sound procedure for the 
reconstruction should be planned if preservation of the 
affected limb is possible. In some cases, amputation 
alone can ensure an adequate surgical margin. One 
must not forget that amputation is one surgical proce-
dure in which functional reconstruction is possible using 
an artifi cial limb. In Japan, lifestyles are gradually be-
coming Westernized. Therefore, when amputation is 
compared with a limb salvage procedure that may 
create greater opportunity for postoperative infection 
or severe joint contracture, amputation may provide 
better quality of life (QOL). There have been reports 
that the survival prognosis is the same in cases with limb 
salvage procedure as in those with amputation. How-
ever, such reports have little clinical signifi cance. An 
adequate surgical margin is important and leads to a 
better outcome, particularly survival prognosis. In cases 
in which a limb salvage procedure cannot achieve com-
plete removal of the primary lesion with an adequate 
surgical margin, the orthopedic surgeon should recom-
mend amputation.
In the 40th Annual Musculoskeletal Tumor Meeting 
of the Japanese Orthopaedic Association, symposium 
and panel discussions of the above-mentioned items 
have been planned. I hope that participation by many 
physicians and energetic discussions among them will 
lead to positive results for patients and their clinical 
outcomes.
The 40th Annual Musculoskeletal Tumor Meeting of 
the Japanese Orthopaedic Association will be held on 
July 12–13, 2007, at Kofu City, Yamanashi Prefecture. 
It is my great honor to have the opportunity to conduct 
that annual meeting.
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